¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transition state intermediate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® vegetative state ÇÑ±Û ½Ä¹°»óÅÂ
¼³¸í   
  ÀÚÀ²½Å°æ°è´Â È°µ¿Çϰí ÀÖÀ¸³ª ¼öÀǿÀÌ ÀüÇô ºÒ´ÉÇÑ »óŸ¦ ¸»ÇÑ´Ù. µû¶ó¼­ È£Èí, ½É¹ÚÀº Áö¼ÓÇϰí ÀÖÀ¸³ª ÀǽÄÀûÀΠȰµ¿À» ÀÏÀ¸Å°´Â ÀÏÀº ÇÒ ¼ö ¾ø´Ù. ¿øÀÎÀº µÎºÎ¿Ü»ó-ôÃß¼Õ»ó-³úÇ÷°ü¼Õ»ó-³úô¼öÁ¾¾ç-Áßµ¶ µî ¿©·¯ °¡Áö°¡ ÀÖÁö¸¸, °¡Àå ¸¹Àº °ÍÀº ±³Åë»ç°í µî¿¡ ÀÇÇÑ ¸Ó¸®¿Ü»óÀÌ´Ù. ´ë³úÀǠǥÃþºÎ´Â ´ë³ú°ÑÁúÀ̶ó Çϴµ¥, ÀÌ °÷¿¡´Â ¹é ¼ö ½Ê¾ïÀÇ ½Å°æ¼¼Æ÷°¡ ¸ð¿© À־ ¿îµ¿-°¨°¢-ÀǽĠµîÀÇ ÀÛ¿ëÀ» ´ã´çÇϰí ÀÖ´Ù. ÀÌ ´ë³ú°ÑÁúÀÇ ¼Õ»óÀ» ÀÔÀ¸¸é ¿îµ¿±â´ÉÀ̳ª ÀǽÄÀÌ Á¤ÁöµÇ°í, ³úÁٱⰡ ´ã´çÇϴ ȣÈí±â´É-¼ÒÈ­±â´É-½ÉÀå¹Úµ¿±â´É ¹Û¿¡ ÇÏÁö ¸øÇϰԠµÈ´Ù.
¿µ¹® persistent vegetative state ÇÑ±Û Áö¼Ó½Ä¹°»óÅÂ
¼³¸í   
  ±× ºÎÀ§¿¡ »ó°ü¾øÀÌ ³ú¼Õ»ó¿¡ ÀÇÇØ¼­ ÀϾ´Â °¢¼º»óÅ¿¡ À־ÀÇ ½ÉÇÑ ¹«¹ÝÀÀ»óÅ·μ­, ´ë³ú°ÑÁúÀÇ ±â´ÉÁ¤Áö, ¿ÜºÎȯ°æ¿¡ ´ëÇÑ ÀûÀýÇÑ ÀûÀÀ¹ÝÀÀÀÇ °á¿©, ¹«µ¿, ¹«¾ðÀ» Æ¯Â¡À¸·Î Çϸç, ³úÆÄ´Â Æòźȭ ¶Ç´Â ÀÌ»óȰµ¿À» ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • demographic transition
    Àα¸ÇÐÀûÀÌÇà
  • phase transition
    À§»óÀüÀÌ
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • intermediate
    1. Áß°£- 2. Áß°£¹°
  • intermediate body
    Áß°£¼Òü
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ, Áß°£¼¼Æ÷±«
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹éÁú
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nerve
    Áß°£½Å°æ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate
    Áß°£-, Áß°£¹°
  • state
    »óÅÂ
  • basal state
    ±âÃÊ»óÅÂ
  • ordinary state
    Á¤»ó»óÅÂ
  • panic state
    °øÈ²»óÅÂ
  • persistent vegetative state
    Áö¼Ó½Ä¹°»óÅÂ
  • postprandial state
    ½ÄÈÄ»óÅÂ
  • refractory state
    ¹«¹ÝÀÀ»óÅÂ
  • relaxation state
    À̿ϻóÅÂ
  • saturation state
    Æ÷È­»óÅÂ
  • steady state
    Ç×Á¤»óÅÂ
  • vegetative state
    ½Ä¹°»óÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • demographic transition
    Àα¸ÇÐÀûÀÌÇà
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀÌÇàÀå¾Ö
  • phase transition
    À§»óÀüÀÌ
  • role transition
    ¿ªÇÒÀüȯ
  • transition ray
    °úµµ¼±, ÀÌÇ༱
  • transition
    º¯ÀÌ, ÀÌÇà, õÀÌ
  • intermediate body
    Áß°£¼Òü
  • intermediate coupling
    Áß°£°áÇÕ
  • intermediate care facility
    Áß°£Ä¡·á½Ã¼³
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate hybrid
    Áß°£ÀâÁ¾
  • intermediate
    Áß°£-, Áß°£¹°
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • age of transition
    °úµµ±â.
  • phase transition
    À§»óÀüÀÌ.
  • range of transition
    Àüȯ¹üÀ§.
  • IDL = intermediate density lipoprotein
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate density lipoprotein =IDL
    Á߹еµÁö´Ü¹é(ñéÚËÓøò·Ó±ÛÜ)
  • Intermediate filaments
    Áß°£¼¼»ç(ñéÊàá¬Þê)
  • Intermediate part(commissura) of bulb
    Áú¾î±Í¸Á¿ïÁß°£ºÎºÐ
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
  • inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
  • pituitary intermediate lobe
    ³úÇϼöüÁß°£¿±, ³úÇϼöüÁß¿±(¡­ñéç¨).
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
  • reactive intermediate
    ¹ÝÀÀ¼º Áß°£¹°Áú.
  • DESS (double echo in the steady state)
    Ç×Á¤ »óÅÂÀÇ ÀÌÁß ¿¡ÄÚ
  • FAST(Fourier acquisition in the steady state) sequen
    Ç×Á¤ »óÅ¿¡¼­ÀÇ Fourier ȹµæ ¿¬¼â
  • Mini-Mental State Examination(MMSE)
    °£ÀÌÁ¤½Å»óŰ˻ç(ÊÛì¯ïñãêßÒ÷¾ËþÞÛ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dream state, dream-like state, dreamy state
    ¸ù·Õ»óÅÂ(ÙÔÖèßÒ÷¾).
  • age of transition
    °úµµ±â.
  • demographic transition
    Àα¸ÇÐÀû ÀÌÇà (ÊÙËöÌ´).
  • phase transition
    À§»óÀüÀÌ.
  • range of transition
    Àüȯ¹üÀ§.
  • role transition(s)
    ¿ªÇÒÀüȯ
  • sleep-wake transition disorder
    ¼ö¸é°¢¼ºÀüȯ±âÀå¾Ö(º´)
  • transition
    õÀÌ.
  • transition element
    ÀüÀÌ¿ø¼Ò(ï®ì¹êªáÈ).
  • transition point
    ÀüÀÌÁ¡(ËøËöËø).
  • transition probability
    ÃßÀÌÈ®·ü(̧ËöÌ·Ëô).
  • transition ray
    °úµµ¼±
  • transition ray
    ÀÌÇ༱
  • transition temperature
    ÀüÀ̿µµ(ï®ì¹è®öô).
  • central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Crypt state
    ¿ò»óÅÂ
    [¿¾ ¿ë¾î] Àº¿Í»óÅÂ
  • Proliferative state
    Áõ½Ä»óÅÂ
    [¿¾ ¿ë¾î] Áõ½Ä±â
  • Vestigial state
    ÈçÀû»óÅÂ
    [¿¾ ¿ë¾î] ÈçÀû»óÅÂ
  • (Intermediate lacunar node)
    (Áß°£Ç÷°üÄ­¸²ÇÁÀý)
    [¿¾ ¿ë¾î] Áß°£¿ä¿ÍÀÓÆÄÀý
  • Lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£Áú¿ÜÃøºÎ
  • Gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] °Å´ë¼¼Æ÷Áß°£¸Á»óüÇÙ
  • Posterior intermediate sulcus
    µÚÁß°£°í¶û
    [¿¾ ¿ë¾î] ÈÄÁß°£±¸
  • Medullary intermediate reticular nucleus
    ¼û³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] ¿¬¼öÁß°£¸Á»óüÇÙ
  • Intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁß°£ºÎ
  • Inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] Çϱ³³úÁß°£¸Á»óüÇÙ
  • Superior pontine intermediate reticular nucleus
    À§´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] »ó±³³úÁß°£¸Á»óüÇÙ
  • Intermediate
    Áß°£
    [¿¾ ¿ë¾î] Áß°£
  • Intermediate branch
    Áß°£°¡Áö
    [¿¾ ¿ë¾î] Áß°£Áö
  • Intermediate hepatic veins
    Áß°£°£Á¤¸Æ
    [¿¾ ¿ë¾î] Áß°£Á¤¸Æ
  • Intermediate zone
    Áß°£±¸¿ª
    [¿¾ ¿ë¾î] Áß°£´ë
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first intermediate host
    Á¦ÀÏÁß°£¼÷ÁÖ
  • intermediate host
    Áß°£¼÷ÁÖ
  • second intermediate host
    Á¦ÀÌÁß°£¼÷ÁÖ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transition state
    õÀÌ»óÅÂ(ôÃì¹ßÒ÷¾)
  • transition state inhibitor
    õÀÌ»óÅ ÀúÇØÁ¦(ôÃì¹ßÒ÷¾îÁúªð¥)
  • transition state theory
    õÀÌ »óÅ ÀÌ·Ð(ôÃì¹ßÒ÷¾×âÖå)
  • common intermediate principle
    °øÅë Áß°£Ã¼¿ø¸®(Íì÷×ñéÊàô÷ê«×â)
  • covalent intermediate
    °øÀ¯°áÇÕ Áß°£»ê¹°(ÍìêóÌ¿ùêñéÊàß§Úª)
  • enzyme-substrate intermediate
    È¿¼Ò-±âÁú Áß°£Ã¼ (ý£áÈÐñòõñéÊàô÷)
  • intermediate
    Áß°£¹°(ñéÊàÚª)
  • lipid intermediate
    ÁöÁúÁß°£´ë»ç¹°(ò·òõñéÊàÓÛÞóÚª)
  • tetrahedral intermediate
    »ç¸éüÇü Áß°£´ë»ç¹° (ÞÌØüô÷û¡ñéÊàÓÛÞóÚª)
  • helix-coil transition
    ³ª¼±(Õ¢àÁ)-ÄÚÀÏ ÃµÀÌ(ôÃì¹)
  • inside out transition
    ³»¿ÜÀüµµ õÀÌ(Ò®èâï´ÓîôÃì¹)
  • isomeric transition
    ¾ÆÀ̼ҸÓÀüÀÌ(ï®ì¹)
  • magnetic transition moment
    ÀÚ±âõÀ§(í¸ÐïôÃêÈ) ¸ð¸àÆ®
  • radiationless transition
    ¹«¹æ»ç¼± ÀüÀÌ(ÙíÛ¯ÞÒàÊï®ì¹)
  • rotational transition
    ȸÀü ÀüÀÌ(üÞï®ï®ì¹)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transition ray
    ÀÌÇ༱
  • intermediate
    Áß°£ÀÇ, Áß°£¹°
  • intermediate field MR scanner
    ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate nerve
    Áß°£½Å°æ
  • CE FAST [=contrast enhanced fast acquisition in the steady state]
    Ç×Á¤»óÅÂÀÇ ´ëÁ¶µµÁõ°­°í¼Óȹµæ
  • DESS [=double echo in the steady state]
    Ç×Á¤»óÅÂÀÇ ÀÌÁß¿¡ÄÚ
  • excitation state
    ¿©±â»óÅÂ, ÈïºÐ»óÅÂ
  • fast imaging with steady state precession [=FISP]
    Ç×Á¤»óż¼Â÷¿îµ¿À» ÀÌ¿ëÇÑ °í¼Ó¿µ»ó
  • FAST(Fourier acquisition in the steady state) sequence
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ¿¬¼â
  • Fourier acquisition in the steady state [=FAST]
    Ç×Á¤»óÅ¿¡¼­ÀÇ Fourierȹµæ
  • partial saturation state
    ºÎºÐÆ÷È­»óÅÂ
  • relaxation state
    À̿ϻóÅÂ
  • saturation state
    Æ÷È­»óÅÂ
  • SSFP [=steady state free precession]
    Ç×Á¤»óÅÂÀÚÀ¯¼¼Â÷
  • steady state
    Ç×Á¤»óÅÂ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IDL Index to Dental Literature; interface definition language; intermediate density lipoprotein; interme...
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen...
IM idiopathic myelofibrosis; immunosuppressive method; implementation monitoring; Index Medicus; indome...
LES Lambert-Eaton syndrome; Lawrence Experimental Station [agar]; local excitatory state; Locke egg seru...
ATN acute tubular necrosis; augmented transition network
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TS transition state
EMT Epithelial-mesenchymal transition
MBT Mid-Blastula-Transition
MPT Mitochondrial Permeability Transition
T(g) The glass transition temperature
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • demographic transition
    Àα¸ÇÐÀû ÀÌÇà
  • reconstructive transition
    Àç°Ç ÀüÀÌ
    ÃÖ±ÙÁ¢ ¹èÀ§´Â º¯ÇÏÁö ¾ÊÁö¸¸, ´ÙÀ½ÀÇ ÀÎÁ¢¿øÀÚ¸¦ ÇöÀúÇÏ°Ô À̵¿½ÃŰ°Å³ª °áÇÕÀ» Àü´ÜÇÔ¿¡ ÀÇÇØ »õ·Î¿î ±¸Á¶¸¦ ¸¸µå´Â ÀüÀÌ.
  • transition
    º¯ÀÌ, ÀüÀÌ, ÀüÀÌÇà
    ÇϳªÀÇ »óÅ¿¡¼­ Á¾·ù°¡ ´Ù¸¥ »óÅ·Πº¯È­ÇÏ´Â °Í. ¿ø¼Ò, ºÐÀÚ µîÀÇ ÀüÀÌ.
  • transition line
    º¯È¯¼±
  • transition ray
    ÀÌÇà ¼±
  • corticotropin-like intermediate lobe peptide

    corticotropin-releasing factor (ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ¿ä¼Ò, ºÎ½Å ÇÇÁú È£¸£¸ó À¯¸® ÀÎÀÚ

  • intermediate
    Áß°£ÀÇ, Áß°£¹°, Áß°£Ã¼, Áß°£¹°Áú
    1. ¾ç±Ø´ÜÀÇ ½Ö¹æ¿¡ ÀϺΠÀ¯»çÇÑ. 2. ¹ÝÀÀÀÇ ÃÖÁ¾ »ê¹° Çü¼º¿¡ ÇʼöÀûÀÎ È­ÇÐ ¹ÝÀÀÀÇ °úÁ¤ Áß¿¡ ¸¸µé¾îÁö´Â ¹°Áú.
  • intermediate body of Flemming
    Ç÷¹¹Ö Áß°£Ã¼
    À¯»ç ºÐ¿­ÀÇ ÃÖÁ¾ ´Ü°è¿¡ À־ µÎ °³ÀÇ ³¶ ¼¼Æ÷¸¦ ¿¬°á½ÃŰ´Â È£»ê¼º ¹°ÁúÀÇ ÀÛÀº Áö¸§ ´Ù¸®.
  • intermediate cell
    Áß°£ ¼¼Æ÷
    ÁßÃþ ÆíÆò »óÇÇ Á¶Á÷ÀÇ Áß°£Ãþ, ÁÖ·Î °ú¸³ ¼¼Æ÷ÃþÀ» Â÷ÁöÇÏ´Â ¼¼Æ÷·Î¼­ ¼¼ Æ÷Áø¿¡¼­´Â Ç¥Ãþ ¼¼Æ÷º¸´Ù ¾à°£ ÀÛ¾Æ 30-50 ¸¶ÀÌÅ©·Î¹ÌÅÍÀÇ ´Ù°¢ÇüÀ̳ª À¯¿øÇüÀÇ ¿¯Àº ¼¼Æ÷ÁúÀ» Áö´Ñ ÆíÆòÇÑ ¼¼Æ÷. ÇÙÀº ¼¼Æ÷ÀÇ Á߽ɿ¡ ÀÖÀ¸¸ç, Ç¥Ãþ ¼¼Æ÷º¸´Ù´Â ¾à°£ Å©°í, ¼ÒÆ÷»óÀÇ ÇÙ³» ±¸Á¶¸¦ °üÂûÇÒ ¼ö ÀÖ´Ù.
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • intermediate junction
    ºÎÂø ¶ì
    µ¿ÀǾî=zonula adherens. Æó¼â ¶ìó·³ ¼¼Æ÷¸¦ ¿ÏÀüÈ÷ µÑ·¯ ½Î¸ç Æó¼â ¶ìÀÇ ¹Ù·Î ¾Æ·¡¿¡ À§Ä¡ÇÑ´Ù. ¼¼Æ÷ »çÀÌ¿¡ ÆøÀÌ 20-25§¬ÀÎ ÀÏÁ¤ÇÑ °ø°£ÀÌ Á¸ÀçÇϴµ¥ ÀÌ °ø°£Àº ÀüÀÚ ¹Ðµµ°¡ ³·¾Æ °ÅÀÇ Åõ¸íÇÏ°Ô º¸À̸ç ÀÌ ¾È¿¡ µé¾î ÀÖ´Â ¹°ÁúÀÌ µÎ °³ÀÇ ÇüÁú¸· ºÎÂø¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¹Ï¾îÁö³ª ¾ÆÁ÷ ¾î¶² ¹°ÁúÀÎÁö´Â ¹àÇôÁ® ÀÖÁö ¾Ê´Ù.
  • intermediate movement
    Áß°£ ÇÏ¾Ç ¿îµ¿
    ÇϾǰñÀÌ ¿îµ¿ÇÒ ¼ö ÀÖ´Â ÃÖ´ëÀÇ ¿îµ¿ ¹üÀ§ ³»¿¡¼­ ÀϾ´Â ¸ðµç ¿îµ¿.
  • intermediate syndrome
    Áß°£Çü ÁõÈıº
  • intermediate zone
    Áß°£´ë, Áß¾ÓºÎ, °üÀý ¿øÆÇ Áß°£ºÎ
  • lateral intermediate substance
    °¡ÂÊ Áß°£ ȸ»öÁú
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
transition state intermediate In a chemical reaction, an unstable and high-energy configuration assumed by reactants on the way to making products. Enzymes are thought to bindand stabilise the transition state, thus lowering the energy of activation needed to drive the reaction to completion.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
transition state The activated state of a molecule that has partly undergone a chemicalreaction.
(09 Oct 1997)
cervicothoracic transition The junction between the last cervical vertebra and first thoracic vertebra.
(05 Mar 2000)
health transition Demographic and epidemiologic changes that have occurred in the last five decades in many developing countries and that are characterised by major growth in the number and proportion of middle-aged and elderly persons and in the frequency of the diseases that occur in these age groups. The health transition is the result of efforts to improve maternal and child health via primary care and outreach services and such efforts have been responsible for a decrease in the birth rate; reduced maternal mortality; improved preventive services; reduced infant mortality, and the increased life expectancy that defines the transition.
(12 Dec 1998)
helix-coil transition <molecular biology> A change in the structure of a nucleic acid or protein molecule from a highly ordered, complex structure to a random, chaotic structure. Also means that the protein or nucleic acid becomes denatured.
(09 Oct 1997)
isomeric transition The transition of a nuclear isomer to a lower quantum state; e.g., 131mXe &rarr; 131Xe + g.
(05 Mar 2000)
transition 1. Passage from one place or state to another; charge; as, the transition of the weather from hot to cold. "There is no death, what seems so is transition." (Longfellow)
2. A direct or indirect passing from one key to another; a modulation.
3. A passing from one subject to another. "[He] with transition sweet, new speech resumes." (Milton)
4. <biology> Change from one form to another.
This word is sometimes pronounced; but according to Walker, Smart, and most other authorities, the customary and preferable pronunciation is, although this latter mode violates analogy. Other authorities say .
<geology> Transition rocks, a term formerly applied to the lowest uncrystalline stratified rocks (graywacke) supposed to contain no fossils, and so called because thought to have been formed when the earth was passing from an uninhabitable to a habitable state.
Origin: L. Transitio: cf. F. Transition. See Transient.
Source: Websters Dictionary
(01 Mar 1998)
transition electron An electron that moves from one energy level to another to fill a vacancy in a shell, with the emission of characteristic radiation.
(05 Mar 2000)
transition mutation A point mutation involving substitution of one base-pair for another, i.e., replacement of one purine for another and of one pyrimidine for another pyrimidine without change in the purine-pyrimidine orientation.
(05 Mar 2000)
transition probability model A model to account for the apparently random variation in cell cycle time between individual animal tissue cells in culture that postulates that transition from G1 to s phase is probabilistic. Contrasts with hypotheses that require the accumulation of critical levels of particular proteins.
(18 Nov 1997)
transition protein <molecular biology> In spermatogenesis, group of proteins that displace histones from nuclear DNA and that are in turn displaced by protamines to produce the transcriptionally inactive nuclear DNA characteristic of the sperm nucleus.
(18 Nov 1997)
transition temperature <chemistry> The temperature at which there is a transition in the organisation of, for example: the phospholipids of a membrane where the transition temperature marks the shift from fluid to more crystalline. Usually determined by using an Arrhenius plot of activity against the reciprocal of absolute temperature, the transition temperature being that temperature at which there is an abrupt change in the slope of the plot. In membranes such phase transitions tend to be inhibited by the presence of cholesterol.
(18 Nov 1997)
absent state The saemiconscious state associated with an epileptic attack.
Synonym: absent state.
(05 Mar 2000)
activated state <chemistry, radiobiology> An atom or nucleus which possesses more energy than its ground state energy.
(16 Dec 1997)
acute confusional state <psychiatry> A condition of severe confusion or rapid change in brain function. This often occurs as the result of a mental illness or physical illness.
Symptoms include lethargy, agitation, confusion, disorientation and delirium.
(27 Sep 1997)
anxiety tension state A milder form of an anxiety disorder.
See: anxiety disorders.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transition
    º¯È­; °úµµ±â
  • demographic transition
    Àα¸ÇÐÀû ÃßÀÌ(Ãâ»ý·ü,»ç¸Á·üÀÇ ÁÖµÈ º¯È­)
  • transition
    º¯Ãµ;º¯ÀÌ;°úµµ±â;(ÀϽÃÀû) ÀüÁ¶
  • intermediate
    Áß°£¿¡ ÀÖ´Â
  • intermediate
    Áß°£ÀÇ;°³ÀçÇÏ´Â;Áß°£¿¡ ÀϾ´Â;Áß°£¹°;ÁßÀç(Áß°³)ÀÚ Áß°£½ÃÇè;ÁßÇüÂ÷;»çÀÌ¿¡ µé¾î°¡´Ù;ÁßÀçÇÏ´Ù;Áß°³ÇÏ´Ù
  • intermediate frequency
    Áß°£Á֯ļö
  • intermediate host
    Áß°£¼÷ÁÖ(±â»ýÃæÀÇ À¯»ý±âÀÇ ¼÷ÁÖ)
  • intermediate range ballistic missile
    Á߰Ÿ® ŸµµÅº
  • intermediate school
    ÁßÇб³;(¹Ì)±¹¹ÎÇб³4-6Çг⠰úÁ¤ÀÇ Çб³;(¿µ)±¹¹ÎÇб³ »ó±Þ°ú ÁßÇб³ÀÇ Áß°£Çб³(12-14¼¼ ÇлýÀ» ¼ö¿ë)
  • intermediate technology
    Áß°£ °øÇÐ(¼Ò±Ô¸ðÀûÀÌ°í °£´ÜÇÑ ¹æ¹ýÀ̳ª ±â¼úÀ» Çö´ëÀÇ Ã·´Ü ±â¼úÀ̳ª ±â°è¿¡ °áºÎ½ÃŲ °øÇÐ)
  • state
    »óÅÂ,±¹°¡,ÁÖ,½ÅºÐ,ÁöÀ§
  • state rights
    ÁÖÀÇ ±Ç¸®
  • state' attorney
    ÁÖ´ëÇ¥ÀÇ º¯È£»ç
  • state's attorney
    ÁÖ´ëÇ¥ÀÇ º¯È£»ç
  • Badger State
    ¹Ì±¹ÀÇ ÁÖ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á